Literature DB >> 23180478

High ceftaroline non-susceptibility in Staphylococcus aureus isolated from acute skin infections in 15 tertiary hospitals in China.

Hui Zhang1, Meng Xiao2,1, Qi-Wen Yang1, Yao Wang1, He Wang1, Ying Zhao1, Mitchell Brown3, Hao-Ran Zhao4, Fanrong Kong3, Ying-Chun Xu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180478     DOI: 10.1099/jmm.0.052522-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  5 in total

1.  PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  S Wesley Long; Randall J Olsen; Shrenik C Mehta; Timothy Palzkill; Patricia L Cernoch; Katherine K Perez; William L Musick; Adriana E Rosato; James M Musser
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types.

Authors:  Meng Xiao; He Wang; Ying Zhao; Lei-Li Mao; Mitchell Brown; Yun-Song Yu; Matthew V N O'Sullivan; Fanrong Kong; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

3.  Ceftaroline fosamil: a brief clinical review.

Authors:  Debbie-Ann T Shirley; Emily L Heil; J Kristie Johnson
Journal:  Infect Dis Ther       Date:  2013-08-08

4.  Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy.

Authors:  Y Wu; J Kang; Q Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-13       Impact factor: 3.267

5.  Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?

Authors:  Birgit Strommenger; Franziska Layer; Ingo Klare; Guido Werner
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.